NLRP3 inflammasomes link inflammation and metabolic disease
- 31 August 2011
- journal article
- review article
- Published by Elsevier BV in Trends in Immunology
- Vol. 32 (8), 373-379
- https://doi.org/10.1016/j.it.2011.05.004
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasomeCell Death & Disease, 2011
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin SensitivityCell Metabolism, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Association between oxidized LDL, obesity and type 2 diabetes in a population‐based cohort, the Health, Aging and Body Composition StudyDiabetes/Metabolism Research and Reviews, 2009
- Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesityCytokine, 2008
- The NALP3 inflammasome is involved in the innate immune response to amyloid-βNature Immunology, 2008
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- The NLR Gene Family: A Standard NomenclatureImmunity, 2008
- Inflammation and metabolic disordersNature, 2006
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006